{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:48Z","timestamp":1790494128093,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019310","name":"Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study","doi-asserted-by":"publisher","award":["2015-351"],"award-info":[{"award-number":["2015-351"]}],"id":[{"id":"10.13039\/501100019310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172890"],"award-info":[{"award-number":["81172890"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.intimp.2021.107411","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T19:55:54Z","timestamp":1612554954000},"page":"107411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intranasal immunization with a rNMB0315 and combination adjuvants induces protective immunity against Neisseria meningitidis serogroup B in mice"],"prefix":"10.1016","volume":"93","author":[{"given":"Zhenyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingxin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107411_b0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fcimb.2017.00256","article-title":"Biological Functions of the Secretome of Neisseria meningitidis","volume":"7","author":"Tommassen","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.intimp.2021.107411_b0010","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.vaccine.2015.01.057","article-title":"A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice","volume":"33","author":"Pajon","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2021.107411_b0015","first-page":"E112","article-title":"Estimates of the burden of meningococcal disease in Italy: implications for prevention and control","volume":"56","author":"Martinelli","year":"2015","journal-title":"J. Prev. Med. Hyg."},{"key":"10.1016\/j.intimp.2021.107411_b0020","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.2147\/IJN.S206210","article-title":"Chimeric hepatitis B virus core particles displaying Neisserial surface protein A confer protection against virulent Neisseria meningitidis serogroup B in BALB\/c mice","volume":"14","author":"Hou","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.intimp.2021.107411_b0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fimmu.2019.00751","article-title":"The development of a vaccine against Meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107411_b0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107411_b0035","article-title":"Crystal structure of outer membrane protein NMB0315 from Neisseria meningitidis","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.intimp.2021.107411_b0040","first-page":"3178","article-title":"Construction and protective immunogenicity of DNA vaccine pNMB0315 against Neisseria meningitidis serogroup B","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2021.107411_b0045","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jmb.2019.04.007","article-title":"Location, location, location-commensalism, damage and evolution of the pathogenic Neisseria","volume":"431","author":"Seifert","year":"2019","journal-title":"J, Mol. Biol."},{"key":"10.1016\/j.intimp.2021.107411_b0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2015.00354","article-title":"Mucosal immunity and B cells in teleosts: effect of vaccination and stress","volume":"6","author":"Parra","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107411_b0055","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.vaccine.2015.03.096","article-title":"Advances and challenges in mucosal adjuvant technology","volume":"33","author":"Newsted","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107411_b0060","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.vaccine.2015.01.013","article-title":"Compound 48\/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice","volume":"33","author":"Zeng","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107411_b0065","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.vaccine.2009.03.069","article-title":"The mast cell activator compound 48\/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen","volume":"27","author":"McGowen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107411_b0070","first-page":"2533","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2021.107411_b0075","doi-asserted-by":"crossref","unstructured":"M.A. EL-M, S.A. Al-Harthi, R.T. Mohamed, MA ELB, N.S. Saudy, Vaccination with Toxoplasma lysate antigen and CpG oligodeoxynucleotides: comparison of immune responses in intranasal versus intramuscular administrations, Parasitol. Res. 2014; 113: 2277\u20132284.","DOI":"10.1007\/s00436-014-3882-0"},{"key":"10.1016\/j.intimp.2021.107411_b0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2017.07.012","article-title":"Nasal nanovaccines","volume":"530","author":"Bernocchi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2021.107411_b0085","first-page":"165","article-title":"Chitosan-based nanoparticles in mucosal vaccine delivery","volume":"73","author":"Mehrabi","year":"2018","journal-title":"Arch. Razi Inst."},{"key":"10.1016\/j.intimp.2021.107411_b0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/acs.molpharmaceut.7b00730","article-title":"Adjuvant activity of poly-epsilon-caprolactone\/chitosan nanoparticles characterized by mast cell activation and IFN-gamma and IL-17 production","volume":"15","author":"Jesus","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2021.107411_b0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1208\/s12249-013-9950-4","article-title":"Validation of a new 96-well plate spectrophotometric method for the quantification of compound 48\/80 associated with particles","volume":"14","author":"Bento","year":"2013","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.intimp.2021.107411_b0100","first-page":"1783","article-title":"Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines","volume":"8","author":"Zhang","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.intimp.2021.107411_b0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/00325481.2019.1696582","article-title":"Understanding immunogenicity assessments for meningococcal serogroup B vaccines","volume":"132","author":"Balmer","year":"2020","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.intimp.2021.107411_b0110","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2020.01.038","article-title":"Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains","volume":"38","author":"Matthias","year":"2020","journal-title":"Vaccine."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2021.107411_b0115","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2172-14-S1-S4","article-title":"Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B","volume":"14","author":"Zayas","year":"2013","journal-title":"BMC Immunol."},{"key":"10.1016\/j.intimp.2021.107411_b0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/apm.12351","article-title":"Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles","volume":"123","author":"Srivastava","year":"2015","journal-title":"APMIS."},{"key":"10.1016\/j.intimp.2021.107411_b0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.msec.2016.03.045","article-title":"Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides","volume":"70","author":"Zhang","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.intimp.2021.107411_b0130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13238-015-0164-2","article-title":"Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies","volume":"6","author":"Wang","year":"2015","journal-title":"Protein Cell."},{"key":"10.1016\/j.intimp.2021.107411_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169501","article-title":"Intranasal immunization using mannatide as a novel adjuvant for an inactivated influenza vaccine and its adjuvant effect compared with MF59","volume":"12","author":"Ren","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.intimp.2021.107411_b0140","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2217\/nnm-2016-0291","article-title":"Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery","volume":"11","author":"Marasini","year":"2016","journal-title":"Nanomedicine (Lond)."},{"key":"10.1016\/j.intimp.2021.107411_b0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijpharm.2016.11.048","article-title":"Improved sustained release of antigen from immunostimulatory DNA hydrogel by electrostatic interaction with chitosan","volume":"516","author":"Ishii-Mizuno","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2021.107411_b0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejpb.2015.03.024","article-title":"Development of a novel adjuvanted nasal vaccine: C48\/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity","volume":"93","author":"Bento","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2021.107411_b0155","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.1201294","article-title":"Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus","volume":"189","author":"Jung","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107411_b0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2002.tb00608.x","article-title":"Neisseria meningitidis serogroup B: laboratory correlates of protection","volume":"34","author":"Vermont","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.intimp.2021.107411_b0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2016.08.059","article-title":"PLGA nano\/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1\/Th17 immune response in a murine model","volume":"513","author":"Li","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2021.107411_b0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000489405","article-title":"Mucosal immune response in nasal-associated lymphoid tissue upon intranasal administration by adjuvants","volume":"10","author":"Takaki","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.intimp.2021.107411_b0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molimm.2019.04.016","article-title":"Immunogenicity and protective efficacy of mucosal delivery of recombinant hcp of Campylobacter jejuni Type VI secretion system (T6SS) in chickens","volume":"111","author":"Singh","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2021.107411_b0180","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.vaccine.2015.04.015","article-title":"MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine","volume":"33","author":"Medini","year":"2015","journal-title":"Vaccine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:28:31Z","timestamp":1761586111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"alternative-id":["S1567576921000473"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107411","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunization with a rNMB0315 and combination adjuvants induces protective immunity against Neisseria meningitidis serogroup B in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107411"}}